FNY Investment Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

FNY Investment Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$247K	–	1163
2020 Q4	$247K	Buy	+100,000	New	+$243K	0.07%	188

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

FNY Investment Advisers's PDLI Position: Q1 2021 in Review

FNY Investment Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 100,000 shares — an estimated $247K sold.

FNY Investment Advisers first reported a position in PDLI in Q4 2020 and held it in 1 quarter. The position peaked at $247K in Q4 2020. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.

FNY Investment Advisers reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
FNY Investment Advisers sold 100,000 PDL BioPharma, Inc. shares in Q1 2021, an estimated $247K.
FNY Investment Advisers first reported a position in PDL BioPharma, Inc. in Q4 2020 and held it in 1 quarter.
FNY Investment Advisers's PDL BioPharma, Inc. position peaked at $247K in Q4 2020.
11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.

Based on FNY Investment Advisers's 13F filing for Q1 2021, filed 12 Apr 2021.